Cisplatin and etoposide (EP-regimen) is superior to cyclophosphamide, epirubicin, and vincristin (CEV-regimen) in small cell lung cancer: results from a randomized phase III trial with 5 years follow-up
2001
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI